IONIS Trademark

Trademark Overview

On Monday, February 23, 2026, a trademark application was filed for IONIS with the United States Patent and Trademark Office. The USPTO has given the IONIS trademark a serial number of 99666317. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, April 15, 2026. This trademark is owned by Ionis Pharmaceuticals, Inc.. The IONIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, biological preparations and substances, therapeutic preparations and substances, namely, nucleic acid-targeted therapeutics; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Biological preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Therapeutic preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders
ionis

General Information

Serial Number99666317
Word MarkIONIS
Filing DateMonday, February 23, 2026
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, April 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, biological preparations and substances, therapeutic preparations and substances, namely, nucleic acid-targeted therapeutics; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Biological preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Therapeutic preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 23, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIonis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010
US

Trademark Events

Event DateEvent Description
Monday, February 23, 2026NEW APPLICATION ENTERED
Monday, February 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 23, 2026APPLICATION FILING RECEIPT MAILED
Thursday, April 2, 2026ASSIGNED TO EXAMINER
Wednesday, April 8, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

ionis autosomal substances preparations pulmonary inflammatory cardiovascular renal neurologic ophthalmologic disorders